Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAGNOLIA
NCT07173855Phase 4Recruiting
- Sponsor
- Scarborough Health Network
- Start
- Nov 2025
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of magnesium in critical illness, sponsored by Scarborough Health Network. Started Nov 2025; status: recruiting.
02
Drugs
magnesium
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT07173855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07173855.